Janux Therapeutics Inc (JANX)

EBITDA Margin

-209.50%

Quarterly · Period ending:

JANX logo

JANX EBITDA Margin

Latest reported-209.50%
JANX Quarterly EBITDA Margin (0.00% → -209.50%)
High-resolution chart · PNG

JANX ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Janux Therapeutics Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
-209.4964%
-640.0214%
0%
-238.12%
0%
0%
0%
-6,275.3986%
-61.2903%
-1,136.4217%
-456.1967%
-439.7298%
-1,611.8259%
-830.3711%
-550.5097%
-907.1704%
-709.5137%
-838.8295%
-826.2376%
-926.5746%
-1,284.8548%
-598.6842%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.